A survey of US and Canadian oncologists' attitudes toward the cost, cost-effectiveness (CE), and reimbursement of cancer drugs

被引：0
|
作者：
Neumann, P.
Berry, S. R.
Nadler, E.
Evans, W. C.
Palmer, J.
Bell, C.
Strevel, E.
Fang, H.
Ubel, P. A.
机构：
[1] Tufts Univ, Ctr Med, Boston, MA 02111 USA
[2] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[3] Baylor Sammons Canc Ctr, Waco, TX USA
[4] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[5] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[6] Univ Toronto, Peel Reg Canc Ctr, Mississauga, ON L5L 1C6, Canada
[7] Univ Michigan, Ctr Decis & Behav Sci, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9502
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs
    Berry, Scott R.
    Bell, Chaim M.
    Ubel, Peter A.
    Evans, William K.
    Nadler, Eric
    Strevel, Elizabeth L.
    Neumann, Peter J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) : 4149 - 4153
  • [2] Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs
    Strand, G. Chauca
    Bonander, C.
    Jakobsson, N.
    Johansson, N.
    Svensson, M.
    [J]. ESMO OPEN, 2022, 7 (05)
  • [3] Oncologists' cost-effectiveness thresholds for new cancer therapies
    Nadler, E
    Eckert, B
    Neumann, P
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 239 - 239
  • [4] COST-EFFECTIVENESS IN DRUGS
    PERLL, M
    [J]. JOURNAL OF MEDICAL EDUCATION, 1979, 54 (07): : 605 - 606
  • [5] Drugs and cost-effectiveness
    Soto, J
    [J]. MEDICINA CLINICA, 2002, 118 (11): : 438 - 439
  • [6] “Cost-effectiveness” Estimates Result in Flawed Decisionmaking in Listing Drugs for Reimbursement
    Roy West
    E. Keith Borden
    Jean-Paul Collet
    Nigel S. B. Rawson
    Robert S. Tonks
    [J]. Canadian Journal of Public Health, 2002, 93 : 421 - 425
  • [7] Drugs price and reimbursement regulation: comparators, endpoints and role of the cost-effectiveness
    Jommi, Claudio
    Apolone, Giovanni
    Scroccaro, Giovanna
    Acciai, Valentina
    Addis, Antonio
    Ardizzoni, Andrea
    Bernardini, Renato
    Bortolami, Alberto
    Brigido, Alessia
    Buzzetti, Giuliano
    Canonico, Pier Luigi
    Caprari, Francesca
    Centanni, Stefano
    Cernetti, Chiara
    Cicchetti, Americo
    Corsico, Giorgio
    Damele, Francesco
    De Braud, Filippo
    Manurita, Sara
    Mennini, Francesco Saverio
    Olivi, Irene
    Parretta, Federica
    Pippo, Lara
    Pulimeno, Stefania
    Riccaboni, Massimo
    Rossi, Giuseppe
    Saleri, Cecilia
    Sinibaldi, Alessandra
    Spandonaro, Federico
    Stefenoni, Cristian
    Visentin, Elena
    Viale, Pierluigi
    Zapparelli, Giuseppina
    Popoli, Patrizia
    [J]. GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2022, 9 : 99 - 104
  • [8] ATTITUDES AND OPINIONS OF DIETETICS PROFESSIONALS TOWARD COST-BENEFIT AND COST-EFFECTIVENESS ANALYSES
    GILBRIDE, JA
    PARKS, SC
    PALAKURTHI, RR
    [J]. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1994, 94 (04) : 386 - 389
  • [9] Cost-effectiveness in Swedish reimbursement decision making
    Engstrom, Andreas
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 34 (01) : S12 - S12
  • [10] COST-EFFECTIVENESS AND REIMBURSEMENT IN PATIENT-CARE
    ANTMAN, KH
    ALEDORT, LM
    YARBRO, J
    WILENSKY, G
    WOJCIK, S
    MONACO, GP
    WINDHAM, S
    [J]. SEMINARS IN HEMATOLOGY, 1989, 26 (03) : 32 - 45
12345